Report Detail

Medical Devices & Consumables Global Artificial Heart and Ventricular Assist Devices Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4513484
  • |
  • 18 February, 2023
  • |
  • Global
  • |
  • 104 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Medical Devices & Consumables

An artificial heart is a device that replaces the heart. Artificial hearts are typically used to bridge the time to heart transplantation, or to permanently replace the heart in case heart transplantation is impossible. A ventricular assist device (VAD) — also known as a mechanical circulatory support device — is an implantable mechanical pump that helps pump blood from the lower chambers of your heart (the ventricles) to the rest of your body. A VAD is used in people who have weakened hearts or heart failure.
According to our (Global Info Research) latest study, the global Artificial Heart and Ventricular Assist Devices market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Artificial Heart and Ventricular Assist Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Artificial Heart and Ventricular Assist Devices market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Artificial Heart and Ventricular Assist Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Artificial Heart and Ventricular Assist Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Artificial Heart and Ventricular Assist Devices market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Artificial Heart and Ventricular Assist Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Artificial Heart and Ventricular Assist Devices market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include SynCardia Systems, Medtronic PLC, Abbott Laboratories, BiVACOR and Berlin Heart, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Artificial Heart and Ventricular Assist Devices market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Artificial Heart
Ventricular Assist Devices
Market segment by Application
Coronary Heart Disease
Cerebrovascular Disease
Peripheral Arterial Disease
Rheumatic Heart Disease
Congenital Heart Disease
Deep Vein Thrombosis
Other
Major players covered
SynCardia Systems
Medtronic PLC
Abbott Laboratories
BiVACOR
Berlin Heart
ABIOMED
LivaNova PLC
CARMAT
Jarvik Heart Inc
Chongqing Yongrenxin Medical
Thoratec
Cleveland Heart
CryoLife
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Artificial Heart and Ventricular Assist Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Artificial Heart and Ventricular Assist Devices, with price, sales, revenue and global market share of Artificial Heart and Ventricular Assist Devices from 2018 to 2023.
Chapter 3, the Artificial Heart and Ventricular Assist Devices competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Artificial Heart and Ventricular Assist Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Artificial Heart and Ventricular Assist Devices market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Artificial Heart and Ventricular Assist Devices.
Chapter 14 and 15, to describe Artificial Heart and Ventricular Assist Devices sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Artificial Heart and Ventricular Assist Devices
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Artificial Heart and Ventricular Assist Devices Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Artificial Heart
    • 1.3.3 Ventricular Assist Devices
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Artificial Heart and Ventricular Assist Devices Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Coronary Heart Disease
    • 1.4.3 Cerebrovascular Disease
    • 1.4.4 Peripheral Arterial Disease
    • 1.4.5 Rheumatic Heart Disease
    • 1.4.6 Congenital Heart Disease
    • 1.4.7 Deep Vein Thrombosis
    • 1.4.8 Other
  • 1.5 Global Artificial Heart and Ventricular Assist Devices Market Size & Forecast
    • 1.5.1 Global Artificial Heart and Ventricular Assist Devices Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Artificial Heart and Ventricular Assist Devices Sales Quantity (2018-2029)
    • 1.5.3 Global Artificial Heart and Ventricular Assist Devices Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 SynCardia Systems
    • 2.1.1 SynCardia Systems Details
    • 2.1.2 SynCardia Systems Major Business
    • 2.1.3 SynCardia Systems Artificial Heart and Ventricular Assist Devices Product and Services
    • 2.1.4 SynCardia Systems Artificial Heart and Ventricular Assist Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 SynCardia Systems Recent Developments/Updates
  • 2.2 Medtronic PLC
    • 2.2.1 Medtronic PLC Details
    • 2.2.2 Medtronic PLC Major Business
    • 2.2.3 Medtronic PLC Artificial Heart and Ventricular Assist Devices Product and Services
    • 2.2.4 Medtronic PLC Artificial Heart and Ventricular Assist Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Medtronic PLC Recent Developments/Updates
  • 2.3 Abbott Laboratories
    • 2.3.1 Abbott Laboratories Details
    • 2.3.2 Abbott Laboratories Major Business
    • 2.3.3 Abbott Laboratories Artificial Heart and Ventricular Assist Devices Product and Services
    • 2.3.4 Abbott Laboratories Artificial Heart and Ventricular Assist Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Abbott Laboratories Recent Developments/Updates
  • 2.4 BiVACOR
    • 2.4.1 BiVACOR Details
    • 2.4.2 BiVACOR Major Business
    • 2.4.3 BiVACOR Artificial Heart and Ventricular Assist Devices Product and Services
    • 2.4.4 BiVACOR Artificial Heart and Ventricular Assist Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 BiVACOR Recent Developments/Updates
  • 2.5 Berlin Heart
    • 2.5.1 Berlin Heart Details
    • 2.5.2 Berlin Heart Major Business
    • 2.5.3 Berlin Heart Artificial Heart and Ventricular Assist Devices Product and Services
    • 2.5.4 Berlin Heart Artificial Heart and Ventricular Assist Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Berlin Heart Recent Developments/Updates
  • 2.6 ABIOMED
    • 2.6.1 ABIOMED Details
    • 2.6.2 ABIOMED Major Business
    • 2.6.3 ABIOMED Artificial Heart and Ventricular Assist Devices Product and Services
    • 2.6.4 ABIOMED Artificial Heart and Ventricular Assist Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 ABIOMED Recent Developments/Updates
  • 2.7 LivaNova PLC
    • 2.7.1 LivaNova PLC Details
    • 2.7.2 LivaNova PLC Major Business
    • 2.7.3 LivaNova PLC Artificial Heart and Ventricular Assist Devices Product and Services
    • 2.7.4 LivaNova PLC Artificial Heart and Ventricular Assist Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 LivaNova PLC Recent Developments/Updates
  • 2.8 CARMAT
    • 2.8.1 CARMAT Details
    • 2.8.2 CARMAT Major Business
    • 2.8.3 CARMAT Artificial Heart and Ventricular Assist Devices Product and Services
    • 2.8.4 CARMAT Artificial Heart and Ventricular Assist Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 CARMAT Recent Developments/Updates
  • 2.9 Jarvik Heart Inc
    • 2.9.1 Jarvik Heart Inc Details
    • 2.9.2 Jarvik Heart Inc Major Business
    • 2.9.3 Jarvik Heart Inc Artificial Heart and Ventricular Assist Devices Product and Services
    • 2.9.4 Jarvik Heart Inc Artificial Heart and Ventricular Assist Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Jarvik Heart Inc Recent Developments/Updates
  • 2.10 Chongqing Yongrenxin Medical
    • 2.10.1 Chongqing Yongrenxin Medical Details
    • 2.10.2 Chongqing Yongrenxin Medical Major Business
    • 2.10.3 Chongqing Yongrenxin Medical Artificial Heart and Ventricular Assist Devices Product and Services
    • 2.10.4 Chongqing Yongrenxin Medical Artificial Heart and Ventricular Assist Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Chongqing Yongrenxin Medical Recent Developments/Updates
  • 2.11 Thoratec
    • 2.11.1 Thoratec Details
    • 2.11.2 Thoratec Major Business
    • 2.11.3 Thoratec Artificial Heart and Ventricular Assist Devices Product and Services
    • 2.11.4 Thoratec Artificial Heart and Ventricular Assist Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Thoratec Recent Developments/Updates
  • 2.12 Cleveland Heart
    • 2.12.1 Cleveland Heart Details
    • 2.12.2 Cleveland Heart Major Business
    • 2.12.3 Cleveland Heart Artificial Heart and Ventricular Assist Devices Product and Services
    • 2.12.4 Cleveland Heart Artificial Heart and Ventricular Assist Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Cleveland Heart Recent Developments/Updates
  • 2.13 CryoLife
    • 2.13.1 CryoLife Details
    • 2.13.2 CryoLife Major Business
    • 2.13.3 CryoLife Artificial Heart and Ventricular Assist Devices Product and Services
    • 2.13.4 CryoLife Artificial Heart and Ventricular Assist Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 CryoLife Recent Developments/Updates

3 Competitive Environment: Artificial Heart and Ventricular Assist Devices by Manufacturer

  • 3.1 Global Artificial Heart and Ventricular Assist Devices Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Artificial Heart and Ventricular Assist Devices Revenue by Manufacturer (2018-2023)
  • 3.3 Global Artificial Heart and Ventricular Assist Devices Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Artificial Heart and Ventricular Assist Devices by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Artificial Heart and Ventricular Assist Devices Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Artificial Heart and Ventricular Assist Devices Manufacturer Market Share in 2022
  • 3.5 Artificial Heart and Ventricular Assist Devices Market: Overall Company Footprint Analysis
    • 3.5.1 Artificial Heart and Ventricular Assist Devices Market: Region Footprint
    • 3.5.2 Artificial Heart and Ventricular Assist Devices Market: Company Product Type Footprint
    • 3.5.3 Artificial Heart and Ventricular Assist Devices Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Artificial Heart and Ventricular Assist Devices Market Size by Region
    • 4.1.1 Global Artificial Heart and Ventricular Assist Devices Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Artificial Heart and Ventricular Assist Devices Consumption Value by Region (2018-2029)
    • 4.1.3 Global Artificial Heart and Ventricular Assist Devices Average Price by Region (2018-2029)
  • 4.2 North America Artificial Heart and Ventricular Assist Devices Consumption Value (2018-2029)
  • 4.3 Europe Artificial Heart and Ventricular Assist Devices Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Artificial Heart and Ventricular Assist Devices Consumption Value (2018-2029)
  • 4.5 South America Artificial Heart and Ventricular Assist Devices Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Artificial Heart and Ventricular Assist Devices Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Artificial Heart and Ventricular Assist Devices Sales Quantity by Type (2018-2029)
  • 5.2 Global Artificial Heart and Ventricular Assist Devices Consumption Value by Type (2018-2029)
  • 5.3 Global Artificial Heart and Ventricular Assist Devices Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Artificial Heart and Ventricular Assist Devices Sales Quantity by Application (2018-2029)
  • 6.2 Global Artificial Heart and Ventricular Assist Devices Consumption Value by Application (2018-2029)
  • 6.3 Global Artificial Heart and Ventricular Assist Devices Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Artificial Heart and Ventricular Assist Devices Sales Quantity by Type (2018-2029)
  • 7.2 North America Artificial Heart and Ventricular Assist Devices Sales Quantity by Application (2018-2029)
  • 7.3 North America Artificial Heart and Ventricular Assist Devices Market Size by Country
    • 7.3.1 North America Artificial Heart and Ventricular Assist Devices Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Artificial Heart and Ventricular Assist Devices Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Artificial Heart and Ventricular Assist Devices Sales Quantity by Type (2018-2029)
  • 8.2 Europe Artificial Heart and Ventricular Assist Devices Sales Quantity by Application (2018-2029)
  • 8.3 Europe Artificial Heart and Ventricular Assist Devices Market Size by Country
    • 8.3.1 Europe Artificial Heart and Ventricular Assist Devices Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Artificial Heart and Ventricular Assist Devices Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Artificial Heart and Ventricular Assist Devices Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Artificial Heart and Ventricular Assist Devices Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Artificial Heart and Ventricular Assist Devices Market Size by Region
    • 9.3.1 Asia-Pacific Artificial Heart and Ventricular Assist Devices Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Artificial Heart and Ventricular Assist Devices Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Artificial Heart and Ventricular Assist Devices Sales Quantity by Type (2018-2029)
  • 10.2 South America Artificial Heart and Ventricular Assist Devices Sales Quantity by Application (2018-2029)
  • 10.3 South America Artificial Heart and Ventricular Assist Devices Market Size by Country
    • 10.3.1 South America Artificial Heart and Ventricular Assist Devices Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Artificial Heart and Ventricular Assist Devices Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Artificial Heart and Ventricular Assist Devices Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Artificial Heart and Ventricular Assist Devices Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Artificial Heart and Ventricular Assist Devices Market Size by Country
    • 11.3.1 Middle East & Africa Artificial Heart and Ventricular Assist Devices Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Artificial Heart and Ventricular Assist Devices Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Artificial Heart and Ventricular Assist Devices Market Drivers
  • 12.2 Artificial Heart and Ventricular Assist Devices Market Restraints
  • 12.3 Artificial Heart and Ventricular Assist Devices Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Artificial Heart and Ventricular Assist Devices and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Artificial Heart and Ventricular Assist Devices
  • 13.3 Artificial Heart and Ventricular Assist Devices Production Process
  • 13.4 Artificial Heart and Ventricular Assist Devices Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Artificial Heart and Ventricular Assist Devices Typical Distributors
  • 14.3 Artificial Heart and Ventricular Assist Devices Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Artificial Heart and Ventricular Assist Devices. Industry analysis & Market Report on Artificial Heart and Ventricular Assist Devices is a syndicated market report, published as Global Artificial Heart and Ventricular Assist Devices Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Artificial Heart and Ventricular Assist Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,770.08
    4,155.12
    5,540.16
    3,232.92
    4,849.38
    6,465.84
    535,711.20
    803,566.80
    1,071,422.40
    290,614.80
    435,922.20
    581,229.60
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report